Protalix BioTherapeutics (PLX) Current Taxes (2023 - 2026)

Protalix BioTherapeutics has reported Current Taxes for 4 years, with the latest figure at $3.2 million in Q1 2026.

• For the quarter ending Q1 2026, Current Taxes fell 7.85% year-over-year to $3.2 million; the trailing twelve-month figure through Mar 2026 stood at $3.2 million (down 7.85% YoY), and the FY2025 full-year result was $2.9 million, down 15.13% from the prior year.
• Current Taxes for Q1 2026 stood at $3.2 million, up from $2.9 million in the prior quarter.
• The five-year high for Current Taxes was $3.7 million in Q2 2025, with the low at $2.4 million in Q3 2025.
• Average Current Taxes over 4 years is $3.2 million, with a median of $3.2 million recorded in 2026.
• Year-over-year, Current Taxes advanced 20.86% in 2024 and retreated 15.13% in 2025.
• Tracing PLX's Current Taxes over 4 years: stood at $2.9 million in 2023, then increased by 20.86% to $3.5 million in 2024, then slipped by 15.13% to $2.9 million in 2025, then grew by 8.58% to $3.2 million in 2026.
• The last three Current Taxes figures came in at $3.2 million (Q1 2026), $2.9 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.

Peer Comparison